p
e
p
e
membran
fusion
lipid
mix
entri
inhibitor
peptid
glycoprotein
h
b
r
c
herp
simplex
viru
hsv
membran
fusion
repres
attract
target
antihsv
therapi
investig
structur
basi
hsv
membran
fusion
identifi
new
target
inhibit
investig
differ
membranotrop
domain
gh
envelop
glycoprotein
observ
fusion
peptid
ad
exogen
abl
inhibit
viral
fusion
like
intercal
viral
fusion
peptid
upon
adopt
function
structur
membran
interestingli
peptid
analog
predict
gh
loop
region
inhibit
viral
plaqu
format
significantli
inhibitori
effect
appear
consequ
abil
partit
membran
aggreg
within
circular
dichroism
spectra
show
peptid
selfassoci
aqueou
lipid
solut
therefor
inhibit
viral
entri
may
occur
via
peptid
associ
counterpart
wildtyp
gh
antivir
activ
peptid
test
provid
attract
basi
develop
new
fusion
peptid
inhibitor
correspond
region
outsid
fusion
protein
heptad
repeat
region
herp
simplex
viru
type
member
aherpesviru
subfamili
requir
four
membran
glycoprotein
mediat
fusion
name
glycoprotein
gd
glycoprotein
b
gb
glycoprotein
h
l
complex
ghl
essenti
fusion
mutant
lack
one
four
glycoprotein
infecti
replic
block
membran
fusion
three
glycoprotein
membran
span
gb
gd
gh
wherea
gl
solubl
glycoprotein
express
virion
cell
surfac
heterodim
gh
besid
gh
traffick
cell
surfac
absenc
gl
complex
least
understood
stage
entri
mammalian
cell
fusion
virion
envelop
cellular
membran
extens
document
aforement
set
distinct
glycoprotein
gd
gb
ghl
necessari
suffici
membran
fusion
follow
stabl
bind
viru
cell
sinc
gd
characterist
fusion
protein
assum
central
fusion
machineri
involv
gb
heterodim
ghl
fact
describ
interact
gd
one
receptor
caus
conform
chang
ntermin
region
gd
enabl
activ
fusogen
process
accord
model
propos
subramanian
geragthi
carri
hemifus
intermedi
sequenti
activ
gh
gb
mainli
two
differ
class
viral
fusion
protein
describ
base
common
postfus
structur
motif
class
prototyp
identifi
orthomyxovirus
paramyxovirus
retrovirus
filovirus
coronavirus
form
homotrim
cleav
proteolit
surfac
subunit
transmembran
subunit
anchor
viral
membran
fusion
protein
extend
rodlik
structur
respons
activ
trigger
hydrophob
ahelix
fusion
peptid
nterminu
transmembran
subunit
expos
abl
penetr
membran
appos
cell
second
conform
chang
bring
togeth
two
heptad
repeat
locat
downstream
fusion
peptid
form
coiledcoil
structur
result
stabl
hairpin
conform
activ
protein
class
share
common
bundl
function
unit
caus
fold
back
fusion
protein
upon
lead
close
contact
viral
cellular
membran
order
allow
lipid
mix
class
ii
protein
flavivirus
alphavirus
besid
fusion
peptid
intern
locat
form
coiledcoil
contain
predominantli
bstrand
secondari
structur
glycoprotein
gener
associ
second
protein
heterodim
activ
repres
cleavag
accessori
protein
lead
irrevers
rearrang
fusion
protein
trimer
protrud
viral
envelop
allow
penetr
intern
fusion
peptid
cell
membran
foldback
movement
bring
two
membran
enough
close
start
merg
contrast
need
cooper
four
glycoprotein
gain
access
target
cell
gb
gh
like
candid
fusion
executor
recent
advanc
structur
featur
hsv
glycoprotein
indic
herpesvirus
may
use
somehow
intermedi
mechan
compon
may
alon
combin
share
characterist
class
class
ii
fusion
protein
recent
solv
crystal
structur
gb
reveal
trimer
ectodomain
made
five
distinct
domain
monom
rodshap
trimer
organ
around
central
helic
core
reminisc
class
fusion
protein
gb
fail
complet
fall
categori
sinc
proteolit
cleav
two
subunit
therefor
lack
ntermin
fusion
peptid
particular
ahel
coiledcoil
core
relat
gb
class
viral
fusion
protein
two
extend
b
hairpin
hydrophob
tip
homolog
fusion
peptid
vsv
g
relat
gb
class
ii
fusion
protein
therefor
third
class
hypothes
like
gb
gh
conserv
among
herpesvirida
famili
resembl
viral
fusion
glycoprotein
intern
put
fusion
peptid
two
hr
region
abl
adopt
coiledcoil
conform
sever
domain
like
import
membran
fusion
identifi
gh
ectodomain
ctermin
region
protein
exampl
certain
mutat
transmembran
tm
region
cytoplasm
tail
affect
fusion
mutat
region
preced
tm
gh
pretransmembran
region
prove
involv
fusion
interact
intim
lipid
membran
sever
aspect
gb
andor
gh
activ
gd
bind
cell
receptor
cooper
direct
fusion
remain
elucid
sever
structur
function
motif
present
differ
viral
fusion
glycoprotein
alreadi
establish
drug
develop
target
exampl
analog
orthomyxoviru
paramyxoviru
hiv
fusion
peptid
block
viral
infect
presum
form
inact
heteroaggreg
second
target
viral
inhibit
prove
region
form
coiledcoil
heptad
repeat
domain
gener
accept
fusion
progress
format
intermedi
prehairpin
conform
place
ntermin
fusion
peptid
near
target
cell
membran
expos
region
intermedi
hr
vulner
bind
synthet
peptid
thu
inhibit
viral
infect
prevent
format
fusogen
trimerofhairpin
peptid
enfuvirtid
potent
inhibitor
activ
low
nanomolar
concentr
competit
interact
domain
prevent
bundl
conform
propos
mechan
inhibit
recent
found
peptid
correspond
cproxim
region
design
virip
inhibit
wide
varieti
strain
interact
fusion
peptid
prevent
insert
target
cell
membran
studi
indic
fusion
peptid
domain
attract
drug
target
date
studi
examin
peptid
fusion
inhibitor
herpesvirus
mainli
focus
analysi
peptid
analog
hr
region
put
fusion
protein
gh
gb
synthet
peptid
model
coil
coil
region
hcmv
describ
inhibit
viral
infect
suscept
cell
gh
gb
found
possess
hr
region
peptid
gh
hr
region
shown
inhibit
fusion
mechan
similar
happen
hcmv
fusion
inhibit
sinc
power
peptid
one
model
nterminu
nevertheless
need
higher
concentr
inhibit
infect
respect
viral
system
although
gh
hr
peptid
appear
inhibit
entri
develop
peptid
fusion
inhibitor
base
nonhr
region
viral
fusion
protein
yet
explor
previous
report
use
physiochem
algorithm
wimleywhit
interfaci
hydrophob
scale
combin
structur
data
could
predict
region
involv
membran
interact
entri
fusion
process
present
studi
extend
previou
work
analyz
infect
inhibitori
potenti
four
region
found
abl
induc
membran
fusion
region
span
entir
gh
sequenc
may
play
import
role
viral
fusion
protein
target
cell
membran
interact
may
therefor
repres
possibl
target
therapeut
interfer
fluorenylmethoxycarbonyl
fmoc
protect
amino
acid
purchas
inbio
pozzuoli
na
itali
novasyn
tga
resin
nova
biochem
darmstadt
germani
reagent
piperidin
pyridin
solidphas
peptid
synthesi
purchas
fluka
sigmaaldrich
milano
itali
trifluoroacet
acid
tfa
acet
anhydrid
appli
biosystem
foster
citi
ca
usa
h
dmf
ch
cn
suppli
labscan
dublin
ireland
acicloguanosin
acv
purchas
sigmaaldrich
gh
sequenc
use
taken
swissprot
databas
access
number
hydropathi
plot
obtain
tmpred
expasi
swiss
institut
bioinformat
membran
protein
explor
mpex
stephen
white
laboratori
http
blancobiomoluciedumpex
previous
report
secondari
structur
predict
perform
use
jpred
softwar
peptid
synthes
use
standard
fmoc
method
multispecif
peptid
synthes
shimadzu
corpor
biotechnolog
instrument
depart
kyoto
japan
previous
report
peptid
sequenc
report
tabl
larg
unilamellar
vesicl
luv
consist
pcchol
necessari
contain
rhope
nbdpe
prepar
accord
extrus
method
hope
et
al
mm
hepe
mm
nacl
ph
lipid
dri
chloroform
solut
nitrogen
ga
stream
lyophil
overnight
fluoresc
experi
dri
lipid
film
suspend
buffer
vortex
lipid
suspens
freezethaw
six
time
extrud
time
polycarbon
membran
mm
diamet
pore
produc
larg
unilamellar
vesicl
lipid
concentr
liposom
suspens
determin
phosphat
analysi
membran
lipid
mix
monitor
use
reson
energi
transfer
assay
ret
report
struck
et
al
assay
base
dilut
nbdpe
donor
rhope
acceptor
dilut
due
membran
mix
result
increas
nbdpe
fluoresc
thu
monitor
chang
donor
emiss
aliquot
peptid
ad
vesicl
vesicl
contain
mol
probe
mix
unlabel
vesicl
ratio
final
lipid
concentr
mm
small
volum
peptid
dimethylsulfoxid
dmso
ad
final
concentr
dmso
peptid
solut
higher
nbd
emiss
nm
follow
excit
wavelength
set
nm
cut
filter
nm
use
sampl
emiss
monochrom
avoid
scatter
interfer
fluoresc
scale
calibr
zero
level
correspond
initi
residu
fluoresc
label
vesicl
valu
correspond
complet
mix
lipid
system
set
fluoresc
intens
vesicl
upon
addit
vv
total
lipid
concentr
fusion
assay
fluoresc
measur
conduct
pcchol
luv
lipid
mix
experi
repeat
least
three
time
result
averag
control
experi
perform
use
scrambl
peptid
dmso
vero
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
carri
lacz
gene
driven
cmv
promot
express
bgalactosidas
propag
previous
describ
peptid
dissolv
dmem
without
serum
use
rang
concentr
experi
conduct
parallel
scrambl
peptid
nopeptid
control
assess
effect
peptid
inhibit
hsv
infect
four
differ
way
treat
cell
monolay
perform
differ
concentr
peptid
mm
ad
inoculum
follow
min
incub
treatment
nonpenetr
virus
inactiv
citrat
buffer
ph
min
incub
cell
cell
incub
h
dmem
supplement
cmc
monolay
fix
stain
xgal
plaqu
number
score
experi
perform
triplic
percentag
inhibit
calcul
respect
nopeptid
control
experi
peptid
cytotox
measur
lactat
dehydrogenas
ldh
assay
carri
accord
manufactur
instruct
use
cytotox
detect
kit
roch
diagnost
spa
milano
itali
cd
spectra
record
use
jasco
spectropolarimet
cm
quartz
cell
room
temperatur
titrat
peptid
mm
variou
percentag
tfe
perform
well
titrat
function
peptid
concentr
buffer
lipid
solut
peptid
mm
prepar
buffer
tfe
lysophosphatydilcholin
lc
suv
peptid
sampl
lipid
prepar
use
follow
protocol
peptid
first
dissolv
tfe
immedi
prepar
peptid
solut
ad
equal
volum
chloroform
solut
contain
appropri
lipid
concentr
solut
dri
nitrogen
ga
stream
lyophil
overnight
dri
sampl
rehydr
deioniz
water
yield
final
lipid
concentr
mm
small
unilamellar
vesicl
suv
lysophosphatydilcholin
lc
prepar
mlv
sonic
spectra
averag
three
consecut
scan
nm
record
band
width
nm
time
constant
scan
rate
nmmin
spectra
record
correct
blank
mean
residu
ellipt
mre
calcul
use
equat
obsdlcn
obsd
ellipt
measur
millidegre
l
length
cell
cm
c
peptid
concentr
moll
n
number
amino
acid
residu
peptid
percentag
helix
calcul
measur
mean
residu
ellipt
nm
use
w
valu
deg
cm
dmol
per
amino
acid
residu
helic
n
number
amino
acid
residu
isol
peptid
ml
solut
mm
phosphat
buffer
ph
mixtur
peptid
mm
mm
sd
incub
min
final
volum
ml
analyz
nativ
gel
electrophoresi
gel
electrophoresi
carri
h
gel
consist
polyacrylamid
stack
gel
separ
gel
constant
amperag
use
biorad
miniprotean
cell
gel
stain
coomassi
brilliant
blue
previous
use
comput
approach
identifi
region
gh
potenti
interact
bilay
membran
wimleywhit
six
region
high
interfaci
hydrophob
identifi
use
mpex
four
prove
capabl
induc
fusion
liposom
vitro
particular
peptid
activ
play
fundament
role
fusion
process
peptid
although
activ
alon
shown
cooper
fusogen
effect
use
combin
activ
peptid
peptid
correspond
region
compris
two
hr
domain
gh
shorter
sequenc
cterminu
name
show
increas
abil
induc
fusion
lipid
vesicl
secondari
structur
predict
reveal
region
residu
compos
two
helic
separ
kink
residu
thu
two
helic
may
differ
function
fusion
mechan
thu
decid
synthes
sequenc
fig
test
fusion
inhibit
experi
previous
report
peptid
gh
abl
induc
fusion
unilamellar
vesicl
luv
compos
pcchol
reveal
probe
dilut
assay
popul
luv
label
nbdpe
rhope
mix
popul
unlabel
luv
increas
amount
peptid
ad
fusion
label
unlabel
vesicl
caus
peptid
result
dilut
label
lipid
therefor
reduc
energi
transfer
nbdpe
rhope
visual
increas
nbd
fluoresc
depend
extent
lipid
mix
peptid
lipid
molar
ratio
analyz
fusion
experi
perform
peptid
order
determin
abil
induc
fusion
increas
amount
peptid
ad
fix
amount
vesicl
order
compar
activ
differ
peptid
percentag
lipid
mix
function
peptid
lipid
molar
ratio
report
fig
peptid
data
demonstr
repres
shorter
ntermin
analog
peptid
compris
hr
domain
gh
unabl
induc
fusion
least
experiment
condit
use
assay
five
peptid
correspond
domain
high
score
wimley
white
hydrophob
previous
shown
interact
biolog
membran
screen
abil
inhibit
plaqu
format
tabl
verifi
peptid
exert
toxic
effect
vero
cell
monolay
expos
differ
concentr
mm
peptid
h
cell
viabil
assay
ldh
assay
statist
differ
observ
viabil
control
untreat
cell
cell
expos
peptid
data
shown
test
whether
peptid
gh
could
affect
hsv
infect
inocul
onto
vero
cell
presenc
absenc
peptid
rang
differ
condit
describ
section
result
shown
fig
dosedepend
inhibit
assay
hsv
entri
peptid
show
nonsignific
activ
mm
contrari
peptid
abl
inhibit
hsv
entri
approxim
inhibit
mm
mm
shorter
peptid
correspond
nterminu
abl
inhibit
hsv
entri
even
effect
result
approxim
inhibit
mm
inhibit
mm
fig
obtain
plaqu
reduct
necessari
mm
mm
peptid
difficult
dissolv
thu
inhibit
mm
strongli
depend
prepar
sampl
data
support
cd
data
report
follow
paragraph
demonstr
peptid
oligomeris
alreadi
mm
experi
therefor
carri
identifi
step
entri
process
inhibit
four
peptid
choos
peptid
concentr
mm
gave
signific
inhibit
previou
experi
fig
coexposur
treatment
without
strong
bia
due
solubl
peptid
compar
effect
three
differ
method
exposur
cell
andor
viru
peptid
fig
effect
experi
shorter
version
abl
inhibit
infect
present
period
viru
attachmententri
cell
fact
activ
postexposur
treatment
cell
infect
min
afterward
peptid
ad
inoculum
activ
cellpreexposur
experi
contrari
peptid
activ
coexposur
cell
preexposur
experi
viru
preincub
experi
scrambl
version
activ
peptid
experi
includ
control
fail
inhibit
infect
similar
experiment
condit
fig
two
activ
peptid
rank
order
potenc
seem
behav
differ
mechan
action
sinc
latter
also
abl
inhibit
viru
infect
treat
cell
viral
challeng
determin
specif
inhibitori
effect
peptid
deriv
gh
test
two
effect
inhibitor
infect
abil
inhibit
infect
unrel
envelop
viru
viru
member
paramyxovirida
fig
panel
c
show
none
peptid
exert
signific
effect
thu
support
view
inhibit
observ
specif
sinc
structur
conform
fusion
peptid
shown
relat
fusogen
activ
secondari
structur
peptid
determin
cd
spectroscopi
measur
water
tfe
suv
condit
test
spectra
reliabl
nm
lightscatt
therefor
shown
report
cd
experi
perform
two
activ
peptid
inhibit
experi
name
cd
spectrum
buffer
solut
indic
random
coil
conform
peptid
fig
decreas
peptid
environment
polar
occur
peptid
transfer
water
membran
interfac
effect
polar
peptid
conform
studi
use
aqueou
mixtur
tfe
fig
presenc
tfe
peptid
alreadi
show
two
neg
band
nm
suggest
adopt
ahel
conform
calcul
helix
content
accord
chakrabartti
et
al
correspond
percentag
helix
peptid
peptid
increas
concentr
tfe
induc
helic
stabil
approxim
result
suggest
peptid
contain
particular
sequenc
amino
acid
nonpolar
environ
adopt
ahel
conform
cd
spectroscopi
also
util
test
whether
two
peptid
creat
oligom
solut
data
clearli
demonstr
peptid
adopt
random
coil
conform
buffer
solut
cd
spectra
remain
practic
unalt
whole
concentr
rang
studi
mm
data
shown
titrat
function
tfe
fig
show
alreadi
presenc
tfe
peptid
adopt
ahel
conform
ratio
ellipt
nm
util
distinguish
monomer
oligomer
state
helic
ratio
equal
peptid
monomer
state
ratio
exce
valu
oligomer
state
data
reveal
presenc
tfe
adopt
ahel
conform
monomeroligom
equilibrium
shift
toward
oligomer
state
ratio
approxim
higher
percentag
tfe
ratio
decreas
indic
monomer
state
lau
et
al
previous
shown
tfe
disrupt
quaternari
structur
ahelic
ie
tfe
denatur
tertiari
quaternari
structur
stabil
hydrophob
interact
thu
assay
secondari
structur
depend
concentr
solut
contain
tfe
condit
show
presenc
oligomer
speci
fig
tfe
peptid
reveal
characterist
ahelix
spectrum
ellipt
strongli
depend
concentr
suggest
format
aggreg
fig
conclud
howev
aggreg
molecular
size
centrifug
remov
precipit
hydrophob
peptid
solut
effect
spectra
furthermor
strong
concentr
depend
helic
would
expect
macroscop
aggreg
ellipt
nm
estim
helic
mm
mm
higher
concentra
tion
start
diminish
mm
approxim
data
reveal
valu
alway
around
indic
peptid
alway
oligomer
state
analysi
perform
titrat
function
tfe
fig
show
tfe
peptid
adopt
ahel
conform
percentag
helix
ratio
ellipt
nm
reveal
percentag
tfe
peptid
oligomer
state
ratio
approxim
higher
percentag
tfe
ratio
approxim
indic
monomer
state
tfe
fig
also
peptid
reveal
characterist
ahelix
spectrum
ellipt
strongli
depend
concentr
suggest
format
aggreg
believ
aggreg
molecular
size
centrifug
effect
spectra
ellipt
nm
estim
helic
mm
mm
mm
decreas
approxim
similar
behaviour
sudden
fall
molecular
ellipt
previous
observ
aggreg
peptid
moreov
two
peptid
show
similar
tendenc
associ
produc
molecular
aggreg
helic
critic
concentr
differ
two
peptid
particular
maximum
ellipt
observ
mm
mm
indic
greater
tendenc
aggreg
fig
oligomer
state
peptid
nativepag
electrophoresi
tendenc
peptid
oligomer
explor
nativepag
fig
use
isol
peptid
peptid
mm
mm
sd
sd
use
previous
determin
aggreg
state
membran
protein
fusion
peptid
analysi
band
pattern
peptid
absenc
presenc
sd
enabl
us
better
understand
oligomer
profil
nativepag
without
sd
mm
mm
sd
reveal
peptid
oligomer
form
higher
order
oligom
compar
fig
absenc
sd
lane
present
one
band
high
molecular
weight
approxim
kda
lane
present
one
main
band
kda
small
band
higher
molecular
weight
presenc
sd
mm
lane
enough
induc
partial
dissoci
oligom
peptid
result
indic
peptid
tendenc
oligomer
give
higher
order
oligom
thu
confirm
cd
data
hydropathi
analysi
base
hydrophobicityatinterfac
scale
propos
wimley
white
enabl
us
detect
six
domain
hsv
gh
may
involv
interact
viru
envelop
host
cell
membran
previous
demonstr
sequenc
gh
abl
induc
rapid
membran
fusion
act
synergist
way
four
peptid
gh
sure
involv
process
close
interact
target
membran
therebi
promot
format
fusion
intermedi
particular
activ
fusion
gh
directli
involv
fusion
process
presum
format
hemifus
intermedi
mechan
wherebi
gh
mediat
hemifus
need
take
account
possibl
larg
glycoprotein
contain
sever
membraneinteract
segment
high
tendenc
locat
interfac
viral
target
membran
previous
report
sendai
viru
hiv
gh
present
fusion
peptid
expos
fusion
loop
rather
ntermin
side
seem
sever
differ
fusogen
domain
need
execut
complet
fusion
moreov
recent
demonstr
region
gh
inde
form
complex
typic
type
fusion
protein
function
inhibitor
infect
recent
prove
domain
two
heptad
repeat
correspond
peptid
membraneinteract
abil
bind
interact
phospholipid
model
membran
although
poorli
fusogen
use
alon
synerg
activ
segment
gh
abil
induc
membran
fusion
parallel
recent
result
report
hiv
loop
domain
peptid
princip
shorter
analog
also
abl
inhibit
entri
interestingli
recent
report
delet
cterminu
aa
replac
heterolog
fusion
peptid
sens
antisens
direct
decreas
infect
less
rel
wtgh
almost
abolish
cellcel
fusion
synthet
peptid
correspond
abl
induc
fusion
lipid
vesicl
effect
even
though
result
fusion
percentag
precis
compar
due
differ
experiment
condit
also
abl
increas
viru
infect
cellcel
fusion
present
studi
investig
sequenc
indic
abl
induc
liposom
fusion
combin
three
fusogen
domain
alon
unabl
significantli
induc
liposom
fusion
present
result
togeth
avail
data
seem
support
hypothesi
cterminu
domain
involv
fusion
contrari
sequenc
unabl
induc
liposom
fusion
strongli
inhibit
viru
infect
analysi
secondari
structur
predict
protein
gh
indic
domain
may
adopt
ahel
structur
kink
prolin
moreov
two
prolin
residu
prolin
toward
cterminu
usual
present
sequenc
interact
membran
support
hypothesi
c
terminu
may
involv
membran
fusion
precipit
otherwis
form
macroscop
aggreg
presenc
membran
least
concentr
assay
cd
studi
mm
strong
depend
secondari
structur
concentr
indic
format
molecular
aggreg
membran
also
confirm
page
experi
inhibit
experi
also
concentr
mm
test
observ
controversi
result
probabl
indic
precipit
peptid
concentr
peptid
show
strongest
inhibitori
effect
observ
peptid
model
fusion
glycoprotein
date
inhibitori
effect
appear
condit
abil
partit
membran
aggreg
within
sinc
peptid
selfassoci
aqueou
lipid
solut
possibl
bind
counterpart
gh
fusion
protein
thu
suggest
inhibit
viral
entri
may
occur
via
peptid
associ
counterpart
wildtyp
gh
main
differ
activ
peptid
analyz
may
intim
interact
host
cell
membran
therefor
abil
partial
inhibit
viral
entri
cell
treat
first
depend
possibl
viru
find
modifi
cell
membran
still
exhibit
surfac
peptid
hand
loop
domain
power
viru
preincub
experi
show
direct
activ
peptid
viral
glycoprotein
moreov
interest
note
activ
viru
preincub
experi
approxim
pfu
incub
presenc
differ
concentr
peptid
thu
indic
high
hydrophob
region
probabl
hidden
avail
interact
peptid
gh
prefusogen
conform
sever
structur
conform
chang
induc
complex
seri
proteinprotein
proteinphospholipid
interact
occur
fusion
protein
howev
littl
known
conform
chang
drive
membran
apposit
overcom
energi
barrier
membran
fusion
evid
sever
domain
essenti
membran
fusion
thu
peptid
involv
fusion
mechan
may
interfer
intramolecular
interact
sever
domain
result
inhibit
entri
studi
requir
defin
inhibitori
mechan
peptid
probabl
due
differ
degre
interact
membran
protein
counterpart
hypothesis
may
steric
hinder
rel
domain
either
prefusogen
intermedi
conform
prevent
complet
function
interact
gh
membran
fuse
inhibit
membran
fusion
repres
attract
target
drug
design
although
studi
need
better
defin
exact
mechan
inhibit
peptid
specif
natur
locat
interact
viral
target
data
shown
work
suggest
domain
compris
two
heptad
repeat
domain
play
signific
role
membran
fusion
provid
altern
approach
develop
viral
peptid
inhibitor
outsid
hr
region
r
e
f
e
r
e
n
c
e
